Coronary Artery Bypass Surgery (CABG) Off or On Pump Revascularization Study

NCT00463294 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 4752

Last updated 2016-09-16

No results posted yet for this study

Summary

I. Main Research Question:

* To compare the risks and benefits of Off-pump Coronary artery bypass surgery (CABG) to On-pump CABG and to determine if one is better than the other.
* The purpose of this pilot study is also to see the rate of recruitment with expertise-based randomization across different hospital settings.

II. Small RCT studies and meta-analyses done so far have not been able to conclusively say which of the procedure is better. A large randomized study is required to establish the risks and benefits associated with both the off-pump and on-pump CABG surgical procedures.

III. The study will look at which of the two techniques reduce major risks associated with CABG.

Conditions

  • the Efficacy and Safety of Off-pump CABG

Interventions

PROCEDURE

Coronary Artery Bypass Graft with the use of CPB

Coronary Artery Bypass Graft (CABG) using median sternotomy, CPB, cardioplegia and complete cross-clamp and no associated or concomitant surgical procedures

PROCEDURE

Coronary Artery Bypass Graft without the use of CPB

Coronary Artery Bypass Graft (CABG) with no associated or concomitant surgical procedures, using median sternotomy and without CPB and cardioplegia

Sponsors & Collaborators

  • McMaster University

    collaborator OTHER
  • University of Oxford

    collaborator OTHER
  • Instituto Dante Pazzanese de Cardiologia

    collaborator OTHER
  • Fu Wai Hospital, Beijing, China

    collaborator OTHER
  • Universidad de La Frontera

    collaborator OTHER
  • Fundación Cardiovascular de Colombia

    collaborator OTHER
  • Charles University, Czech Republic

    collaborator OTHER
  • Hopital Jean Minjoz

    collaborator OTHER
  • Centre for Chronic Disease Control, India

    collaborator OTHER
  • Ospedale Santa Croce-Carle Cuneo

    collaborator OTHER
  • Medical University of Gdansk

    collaborator OTHER
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER
  • Ankara University

    collaborator OTHER
  • Hotel Dieu Hospital

    collaborator OTHER
  • Centre hospitalier de l'Université de Montréal (CHUM)

    collaborator OTHER
  • SAL Hospital, Ahmedabad, India

    collaborator UNKNOWN
  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • Lamy Andre, MD, MSc · McMaster University

  • Salim Yusuf, MD, DPhil · Population Health Research Institute

  • David Taggart, MD · University of Oxford

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2012-03-31
Completion
2016-09-30

Countries

  • Argentina
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Czechia
  • France
  • India
  • Italy
  • Poland
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00463294 on ClinicalTrials.gov